Gene Therapy for Metastatic Castration‐Resistant Prostate Cancer Using the JC Polyomavirus ( JCPyV ) Virus‐Like Particles as a Gene Delivery Vector
Cancer Medicine · 2026
DOI: 10.1002/cam4.72365 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Chih-Chieh Chou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Biology, National Chung Cheng University, Chiayi, Taiwan. Hauptthemen laut MEDLINE: Genetic Therapy, JC Virus, Genetic Vectors, Prostatic Neoplasms, Castration-Resistant. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: SKBIO Biopharmaceuticals Corp..
Abstract (Originalsprache)
Background
Systemic metastasis remains the leading cause of mortality in patients with advanced prostate cancer, particularly in castration‐resistant prostate cancer (CRPC), for which effective systemic therapeutic options are limited. Gene therapy is a potential strategy for achieving selective tumor targeting and systemic disease control in metastatic settings. This study aimed to establish a systemic metastasis animal model for CRPC and evaluate the therapeutic efficacy of JC polyomavirus (JCPyV) virus‐like particle (VLPs)–based gene therapy against metastatic disease.
Methods
A near‐infrared fluorescent protein (iRFP)‐expressing CRPC cell line was used to establish a systemic metastasis model by tail‐vein injection in mice. The therapeutic efficacy of JCPyV VLPs carrying a prostate‐specific antigen (PSA) promoter‐driven suicide gene (PSAtk‐VLPs), administered in combination with ganciclovir (GCV), was evaluated longitudinally by fluorescence molecular tomography (FMT), with enzalutamide/leuprorelin acetate (ENZ/LEU) included as a clinical treatment comparator.
Results
CRPC metastases in the lungs, liver, spleen, kidneys, and bones were detected by FMT in real time. Control mice exhibited exponential CRPC growth, whereas ENZ/LEU treatment delayed CRPC progression. PSAtk‐VLPs/GCV significantly inhibited the growth of metastatic CRPC. However, no significant differences in survival were observed among the MOCK, ENZ/LEU, and PSAtk‐VLP/GCV groups (log‐rank test, p = 0.7351).
Conclusion
These findings support that JCPyV‐derived virus‐like particles constitute a promising therapeutic approach for metastatic CRPC, enabling systemic delivery of suicide gene therapy with selective inhibition of tumor growth and translational relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Molecular Biology, National Chung Cheng University, Chiayi, Taiwan.
- Department of Anatomic Pathology, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-Yi, Taiwan.
- Department of Pharmacy, Chiayi Chang Gung Memorial Hospital, Puzi, Taiwan.
- Department of Microbiology and Immunology, School of Medicine, Chung-Shan Medical University and Clinical Laboratory, Chung-Shan Medical University Hospital, Taichung, Taiwan.
- Department of Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, Taichung, Taiwan.
- Department of Urology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi, Taiwan.
ORCID-Profile: Chiung-Yao Fang
Förderung
- SKBIO Biopharmaceuticals Corp.
Zitieren
APA
Chou, C. C., Tseng, C. E., Lin, Y. S., Wang, M., Chen, P. L., Chang, D., Shen, C. H., & Fang, C. Y. (2026). Gene Therapy for Metastatic Castration‐Resistant Prostate Cancer Using the JC Polyomavirus ( JCPyV ) Virus‐Like Particles as a Gene Delivery Vector. Cancer Medicine. https://doi.org/10.1002/cam4.72365
Vancouver
Chou CC, Tseng CE, Lin YS, Wang M, Chen PL, Chang D, et al. Gene Therapy for Metastatic Castration‐Resistant Prostate Cancer Using the JC Polyomavirus ( JCPyV ) Virus‐Like Particles as a Gene Delivery Vector. Cancer Medicine. 2026. doi:10.1002/cam4.72365
BibTeX
@article{Chou2026,
author = {Chou, Chih-Chieh and Tseng, Chih-En and Lin, Yu-Shih and Wang, Meilin and Chen, Pei-Lain and Chang, Deching and Shen, Cheng-Huang and Fang, Chiung-Yao},
title = {Gene Therapy for Metastatic Castration‐Resistant Prostate Cancer Using the JC Polyomavirus ( JCPyV ) Virus‐Like Particles as a Gene Delivery Vector},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.72365}
}
EUVIMED